Miromatrix Medical (MIRO) Stock Analysis

What Miromatrix Medical does

Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.

Key metrics

ETFs linked to MIRO

Broad-market and Healthcare sector ETFs an investor holding Miromatrix Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MIRO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Miromatrix Medical?

Miromatrix Medical trades under the ticker MIRO on NASDAQ.

Which exchange is MIRO listed on?

MIRO is listed on NASDAQ.

What sector does Miromatrix Medical operate in?

Miromatrix Medical is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MIRO in a portfolio?

PortView shows MIRO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.